Gattaz W F, Hübner C V, Nevalainen T J, Thuren T, Kinnunen P K
Central Institute of Mental Health, Mannheim, F.R.G.
Biol Psychiatry. 1990 Sep 15;28(6):495-501.
Phospholipase A2 (PLA2) is a key enzyme in the metabolism of phospholipids. Because a disordered phospholipid metabolism has frequently been reported in schizophrenia, we investigated the PLA2 activity in serum from 14 drug-free paranoid schizophrenic patients, 20 healthy controls, and 8 nonschizophrenic psychiatric patients. Schizophrenics showed significantly higher PLA2 activity than healthy controls and nonschizophrenic patients. The increment in schizophrenics was not due to increased concentration of pancreatic secretory PLA2, as concerning pancreatic PLA2 no differences were found among the 3 proband groups. The present findings confirm the results of our previous study and suggest that increased serum PLA2 activity might reflect an increment in the intracellular enzyme activity in schizophrenia. In the brain the activation of intracellular PLA2 results in changes in neuronal activity due to alterations in receptor sensitivity and in neurotransmitter metabolism. The possibility that such PLA2-induced mechanisms are involved in the pathogenesis of schizophrenia should be investigated in further experiments.
磷脂酶A2(PLA2)是磷脂代谢中的关键酶。由于精神分裂症患者中经常报道存在磷脂代谢紊乱,我们对14例未服用药物的偏执型精神分裂症患者、20例健康对照者和8例非精神分裂症的精神病患者血清中的PLA2活性进行了研究。精神分裂症患者的PLA2活性显著高于健康对照者和非精神分裂症患者。精神分裂症患者PLA2活性的升高并非由于胰腺分泌型PLA2浓度增加,因为在这3组被试组中未发现胰腺PLA2存在差异。目前的研究结果证实了我们之前研究的结果,并表明血清PLA2活性升高可能反映了精神分裂症患者细胞内酶活性的增加。在大脑中,细胞内PLA2的激活会由于受体敏感性和神经递质代谢的改变而导致神经元活动的变化。这种由PLA2诱导的机制参与精神分裂症发病机制的可能性应在进一步的实验中进行研究。